Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Harper
B Reeves

Showing results (761-770 of 779) with videos related to

Pageof 78
Sort By:
Science Advances|November 16, 2022
Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetesAbhishek Nag, Ryan S Dhindsa, Jonathan Mitchell, et al.
Nature|December 1, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantationChristian Gaebler, Samad Kor, Kristina Allers, et al.
Brain : a Journal of Neurology|October 25, 2024
Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohortsSophie N M Binks, Katherine S Elliott, Sergio Muñiz-Castrillo, et al.
Nature Communications|December 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trialsDaniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.
Mbio|September 9, 2025
Bayesian estimation of HIV acquisition dates for prevention trialsRaabya Rossenkhan, Elena E Giorgi, Danica Shao, et al.
EPJ Data Science|December 20, 2016
Enhancing disease surveillance with novel data streams: challenges and opportunitiesBenjamin M Althouse, Samuel V Scarpino, Lauren Ancel Meyers, et al.
Nature Medicine|August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B Gilbert, Yunda Huang, Allan C deCamp, et al.
Nature Communications|April 3, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
Pageof 78

Showing results (761-770 of 779) with videos related to

Sort By:
Pageof 78
Science Advances|November 16, 2022
Human genetics uncovers <i>MAP3K15</i> as an obesity-independent therapeutic target for diabetesAbhishek Nag, Ryan S Dhindsa, Jonathan Mitchell, et al.
Nature|December 1, 2025
Sustained HIV-1 remission after heterozygous CCR5Δ32 stem cell transplantationChristian Gaebler, Samad Kor, Kristina Allers, et al.
Brain : a Journal of Neurology|October 25, 2024
Novel risk loci in LGI1-antibody encephalitis: genome-wide association study discovery and validation cohortsSophie N M Binks, Katherine S Elliott, Sergio Muñiz-Castrillo, et al.
Nature Communications|December 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trialsDaniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.
Mbio|September 9, 2025
Bayesian estimation of HIV acquisition dates for prevention trialsRaabya Rossenkhan, Elena E Giorgi, Danica Shao, et al.
EPJ Data Science|December 20, 2016
Enhancing disease surveillance with novel data streams: challenges and opportunitiesBenjamin M Althouse, Samuel V Scarpino, Lauren Ancel Meyers, et al.
Nature Medicine|August 22, 2022
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisitionPeter B Gilbert, Yunda Huang, Allan C deCamp, et al.
Nature Communications|April 3, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
Pageof 78